Polycitra-LC and Ranibizumab ophthalmic
Determining the interaction of Polycitra-LC and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: citric acid / potassium citrate / sodium citrate
Brand name: Cytra-3, Polycitra, Polycitra-LC, Tricitrates, Virtrate-3
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Polycitra-LC-Ranitidine
- Polycitra-LC-Ranitidine Capsule
- Polycitra-LC-Ranitidine Hydrochloride
- Polycitra-LC-Ranitidine Injection
- Polycitra-LC-Ranitidine Suspension
- Polycitra-LC-Ranitidine Syrup
- Ranibizumab ophthalmic-Polyethylene Glycol 3350 NF PEGYLAX
- Ranibizumab ophthalmic-Polyethylene Glycol
- Ranibizumab ophthalmic-Polyethylene glycol 3350
- Ranibizumab ophthalmic-Polyethylene glycol 3350 and electrolytes
- Ranibizumab ophthalmic-Polyethylene glycol 3350, electrolytes, and ascorbic acid
- Ranibizumab ophthalmic-Polyethylene glycol 3350, sodium and potassium salts